Varicose Vein Treatment Market By Treatment Type (Endovenous Ablation, Sclerotherapy, Surgical Procedures, Compression Therapy), and By End User - Global Industry Outlook, Key Companies (Medtronic Plc, Boston Scientific Corporation, AngioDynamics Inc., and others), Trends and Forecast 2025-2034

The Global Varicose Vein Treatment Market is expanding at a considerable rate, driven by the increasing prevalence of venous diseases globally. The aging population, sedentary lifestyle, and obesity have led to the rising incidence of varicose veins. Over 30% of the global population is estimated to be afflicted with varicose veins, with a larger number of females. The market is being driven by the development of minimally invasive procedures such as endovenous laser treatment (EVLT) and radiofrequency ablation (RFA), which offer faster recovery and fewer complications compared to traditional surgery. Growing awareness of cosmetic treatments and improved reimbursement policies in developed nations further augment market growth.

A key opportunity for the varicose vein treatment market is the increasing demand for non-invasive treatments. Patients are now choosing outpatient procedures due to reduced hospital stays and lower costs of treatment. Additionally, the developing countries of the Asia-Pacific and Latin American regions provide untapped opportunities due to improved healthcare infrastructure and rising disposable income. Next-generation laser and sclerotherapy procedures, with better treatment outcomes and patient comfort, are promoting greater acceptance among medical practitioners.

Despite positive growth, the market is faced with restraints such as high procedural costs, particularly in low-income nations where affordability is a problem. Limited access to advanced treatment facilities in rural areas also inhibits the growth of the market. Risks associated with certain procedures, such as nerve damage or deep vein thrombosis, also cause apprehension in patients and physicians. Regulatory hurdles and reimbursement problems in developing economies also slow down market entry.

The growing aging population, which is at greater risk of varicose veins, along with increased investment in healthcare infrastructure, will drive demand. North America leads the market, with the largest revenue share, but Asia-Pacific will see the fastest growth rate due to an expanding patient pool and wider adoption of newer treatment technologies.

The US Varicose Vein Treatment Market

The US Varicose Vein Treatment Market is projected to be valued at USD 666.7 million in 2025. It is expected to witness subsequent growth in the upcoming period as it holds USD 1,145.7 million in 2034 at a CAGR of 6.2%.

The U.S. Varicose Vein Treatment Market is growing steadily, driven by a high prevalence of venous disease and advanced healthcare infrastructure. Over 40 million Americans suffer from varicose veins, and women are twice as likely as men to develop the condition. The aging population is another driver for the increasing demand for varicose vein treatments, with over 20% of the adult population aged over 60 years suffering from chronic venous insufficiency. The market growth is also aided by the availability of large players, continuous technological development, and favorable insurance coverage for vein treatments.

The U.S. population advantage is a significant market-driving factor. With the population aging at a faster rate and the incidence of obesity increasing, the demand for minimally invasive treatments such as EVLT and RFA is increasing. The robust healthcare infrastructure in the nation ensures early diagnosis and treatment, reducing complications. Growing numbers of ambulatory surgical centers specializing in vein treatments enhance patient access. The growing trend of cosmetic vein procedures, particularly in urban areas, is also boosting market growth.

The U.S. market enjoys the benefit of complete reimbursement policies, which reduce the out-of-pocket expenses of patients for availing the necessary vein procedures. With increasing awareness and demand for outpatient procedures, the market is expected to grow shortly. The ongoing introduction of advanced devices and techniques will further consolidate the position of the U.S. as a prominent market in the varicose vein treatment market worldwide.

Global Varicose Vein Treatment Market: Key Takeaways

• The Global Market Size Insights: The Global Varicose Vein Treatment Market size is estimated to have a value of USD 2,136.9 million in 2025 and is expected to reach USD 3,813.6 million by the end of 2034.
• The US Market Size Insights: The US Varicose Vein Treatment Market is projected to be valued at USD 666.7 million in 2025. It is expected to witness subsequent growth in the upcoming period as it holds USD 1,145.7 million in 2034 at a CAGR of 6.2%.
• Regional Market Insights: North America is expected to have the largest market share in the Global Varicose Vein Treatment Market with a share of about 37.10% in 2025.
• Key Players Insights: Some of the major key players in the Global Varicose Vein Treatment Market are Medtronic plc, Boston Scientific Corporation, AngioDynamics, Inc., Teleflex Incorporated, Merit Medical Systems, Inc., BTG International Ltd (a Boston Scientific company), VVT Medical Ltd., and many others.
• Global Market Growth Rate: The market is growing at a CAGR of 6.6% over the forecasted period of 2025.

Global Varicose Vein Treatment Market: Use Cases

• Chronic Venous Insufficiency Management: People with chronic venous insufficiency (CVI) typically require varicose vein treatments to prevent complications such as leg ulcers and skin discoloration. Endovenous ablation and compression therapy enhance the flow of blood, which reduces symptoms such as pain and swelling. Treatment at an early stage prevents the onset of more severe venous disorders.
• Cosmetic and Aesthetic Procedures: A majority of individuals get varicose vein procedures done for cosmetic reasons, as visible veins on the legs can impact confidence. Sclerotherapy and laser ablation are highly effective at eliminating ugly veins with minimal downtime. Increasing focus on aesthetic enhancement, especially among middle-aged people, is driving demand for the procedures.
• Post-Pregnancy Varicose Vein Treatment: Pregnancy is one of the significant risk factors for varicose veins due to hormonal changes and increased pressure on the veins in the legs. The majority of women opt for treatment after pregnancy to alleviate symptoms and prevent complications. Foam sclerotherapy and compression therapy are minimally invasive and effective treatment options for new mothers.
• Occupational Health and Treatment: Healthcare, retail, and hospitality are professions that entail long hours of standing, some of the predisposing factors for varicose veins. Workers who experience pain typically undergo treatment to enhance productivity and prevent further worsening of the condition. Compression therapy and laser treatments alleviate the symptoms, reducing absenteeism due to vein issues.
• Elderly Patient Care and Mobility Improvement: Older people are more susceptible to varicose veins because of weakened valves in the veins and decreased physical activity. Radiofrequency ablation and vein stripping are some of the treatments that improve blood circulation, decreasing pain and swelling in the legs. This allows the elderly to have better mobility, enabling them to lead an active life with fewer complications.

Global Varicose Vein Treatment Market: Stats & Facts

• Research by ACP Microsite indicates that over 40 million Americans are currently suffering from varicose veins, making it one of the most prevalent vascular disorders affecting individuals nationwide - particularly older adults and those who carry genetic predisposition.
• Findings by the Chicago Vein Institute reveal that nearly 50% of individuals suffering from varicose veins have a family history of the condition, highlighting the key role hereditary factors play in increasing risk for this circulatory disorder.
• A study from the Chicago Vein Institute indicates that when both parents have varicose veins, their offspring's chances of inheriting it increase to almost 90% - underscoring its strong genetic component and implicating significant familial risk factors in its onset.
• Medical Dialogues estimates that approximately 25% of India's population suffer from varicose veins, an underdiagnosed condition. Recent developments in non-invasive treatment methods provide increased accessibility even to rural and underserved areas.
• Data from Chicago Vein Institute suggests that, if one parent has varicose veins, daughters have a 60% risk while sons stand a 25% chance.
• ACP Microsite's insights reveal that women are more prone to varicose veins than men due to hormonal influences and genetic predisposition factors affecting vein circulation. Women account for 55% of varicose vein cases versus 44% among men.
• Research by the Chicago Vein Institute indicates that approximately 41% of women over age 50 suffer from varicose veins, further evidenced by its increased prevalence among older people.
• Statistics from ACP Microsite reveal that nearly 50% of U.S. adults over the age of 50 are affected by varicose veins, underscoring its widespread impact and stressing the importance of proactive management.
• Studies conducted by the Chicago Vein Institute indicate that women with BMIs between 25-29.9 have an increased risk of varicose veins than those within the normal BMI range, further emphasizing obesity's role in vein insufficiency.
• Findings from ACP Microsite reveal that obese women with BMIs exceeding 30 are three times more likely to experience varicose veins compared to individuals maintaining lower body mass index levels, further evidence of obesity's negative influence on venous health.
• Reports from the Chicago Vein Institute indicate that varicose veins most frequently impact great and small saphenous veins that lie between fascia and skin, leading to circulatory discomfort, swelling, and progressive venous insufficiency.
• Studies conducted by ACP Microsite indicate that up to 30% of the world population may experience varicose veins, with higher incidence among older individuals, overweight people, and those who inherit susceptibility genes for this condition.
• Data published by the Chicago Vein Institute suggests that varicose veins occur at an incidence rate ranging from 39.4-51.9 cases per 1000 individuals over two years, reflecting its widest possible spread across demographic groups.
• Analysis by ACP Microsite estimates that more than 40 million Americans currently suffer from varicose veins, both men and women alike; most commonly among aging populations with predisposing risk factors.
• Studies cited by the Chicago Vein Institute indicate that among individuals aged 50 or over, almost 50% of women and 40% of men experience varicose veins; gender-based differences exist in prevalence rates for varicose veins.
• Research by ACP Microsite indicates that the likelihood of varicose veins increases significantly with increasing age, particularly after 70 due to weakening vein walls and impaired circulatory function over time.
• According to research by the Chicago Vein Institute, up to 50% of women and 30% of men may develop varicose veins at some point, underscoring its widespread impact across age groups and lifestyles.
• Data provided by ACP Microsite indicates that in Europe, varicose vein prevalence varies considerably by gender and regional considerations; between 20% to 40% for women and 10-20% for men, respectively.
• Reports by the Chicago Vein Institute show that approximately 25% of Australian adults suffer from varicose veins, making this condition widespread across both urban and rural populations. Therefore, greater awareness must be created as well as strategies for early intervention strategies to manage its prevalence effectively.
• Medical Dialogues published a study that revealed nearly 30% of individuals over 40 in India suffer from varicose veins, underscoring the need for improved public health education and access to effective treatment solutions.

Global Varicose Vein Treatment Market: Market Dynamic

Driving Factors in the Global Varicose Vein Treatment Market

Rising Prevalence of Varicose Veins and Chronic Venous Diseases
The burden of varicose veins worldwide is growing, with the condition occurring in almost 30% of the adult population. The condition is more common in women, the elderly, and obese populations, due to hormonal changes, sedentary lifestyles, pregnancy, and frequent standing or sitting. The rising incidence of chronic venous insufficiency (CVI) a more advanced vein dysfunction further increases the demand for effective therapies. 

The healthcare industry’s emphasis on preventive medicine has also played a critical role in enhancing awareness, early detection, and early treatment, resulting in higher uptake of varicose vein therapies. Government and private healthcare initiatives in vein health awareness have also aided in better patient outcomes and increased adoption of treatment.

Advancements in Laser and Radiofrequency Technologies
Constant innovation in laser and radiofrequency-based vein treatment has significantly improved procedural efficiency and patient comfort. Modern endovenous laser therapy (EVLT) and radiofrequency ablation (RFA) systems provide better accuracy, faster recovery time, and lower recurrence rates than conventional surgical techniques. 

Newer robotic-assisted vein treatment procedures allow for better accuracy and controlled energy delivery, reducing the risk of thermal injury and post-procedure complications. Additionally, the development of biodegradable sclerosing agents and nanotechnology-based vein occlusion methods is enhancing the safety and long-term effectiveness of procedures. Research on integrating AI-powered imaging systems with varicose vein procedures is also increasing, advancing the precision and personalization of procedures.

Restraints in the Global Varicose Vein Treatment Market

High Cost of Treatment and Limited Insurance Coverage in Some Regions
Despite advances in varicose vein procedures, high procedure costs remain a significant restraint, particularly in middle- and low-income countries. EVLT and RFA procedures can cost between $2,000 and $5,000 per leg, making them inaccessible to a large majority of the population worldwide. While some health insurance policies reimburse varicose vein procedures when medically necessary, many cosmetic vein procedures are not reimbursed, leaving patients with high out-of-pocket expenses.

Additionally, the cost of advanced laser and radiofrequency equipment is too prohibitive for smaller healthcare facilities and clinics, limiting their ability to offer these services. Greater insurance coverage and the introduction of cost-effective treatment solutions will be significant in overcoming this market restraint.

Risk of Post-Treatment Complications and Recurrence
While modern varicose vein treatments have high success rates, complications such as deep vein thrombosis (DVT), nerve damage, burns, hyperpigmentation, and post-procedure pain remain concerns. Recurrent varicose veins occur in a subset of patients, requiring repeat procedures or long-term compression therapy. Complications are more common in patients with underlying vascular disease, obesity, or diabetes, which limits treatment success in certain populations. 

Pain perception, recovery time, and procedural risk also deter some patients from seeking advanced varicose vein treatments. The market needs to overcome these limitations by streamlining post-procedure care, minimizing recurrence rates, and enhancing patient education.
Opportunities in the Global Varicose Vein Treatment Market

Expansion in Emerging Markets
Developing economies such as Asia-Pacific, Latin America, and the Middle East & Africa present tremendous untapped potential for companies offering varicose vein treatments. Rising healthcare expenditure, patient awareness, and improving medical infrastructure are propelling market growth in countries such as China, India, Brazil, and Mexico. Further, the surging medical tourism industry in these economies presents favorable growth opportunities, with international patients visiting these countries in pursuit of low-cost yet quality vein treatments. Governments in emerging economies are also launching public-private initiatives to improve access to advanced medical devices and minimally invasive procedures, leading to broader adoption of new technologies for vein treatments.

Increasing Investment in Research & Development
The varicose vein treatment market is witnessing heavy investments in next-generation treatments. Players in the industry are focusing on optimizing laser wavelengths, simplifying catheter designs, and creating better radiofrequency ablation techniques for higher efficacy and lower recurrence rates. Growing focus on biocompatible sclerotherapy agents that minimize adverse reactions and improve rates of vein closure is another trend.

The treatment scope is also expanding through research in 3D vein mapping technologies, nanomedicine-based vein occlusion, and AI-driven diagnostic systems. Smart compression therapy wearables, which monitor venous pressure and blood flow in real-time, are another area of research and development, with sizeable growth opportunities in both treatment and post-procedure management.

Trends in the Global Varicose Vein Treatment Market

Rising Adoption of Minimally Invasive Procedures
Minimally invasive treatments such as endovenous laser therapy (EVLT), radiofrequency ablation (RFA), and foam sclerotherapy are increasingly gaining popularity at a fast rate as safer and more effective alternatives to traditional surgeries. These new modalities cut down on hospital stays, post-procedure pain, and the incidence of complications such as infections and deep vein thrombosis (DVT) by a significant margin. 

Outpatient treatments have been increasing, driven by demand for faster recovery and less disruption in daily activities. Hospitals and ambulatory surgical centers are investing in next-generation laser and radiofrequency devices, enhancing procedural accuracy and patient outcomes. The use of needle-based and catheter-assisted procedures guarantees minimal scarring and lower recurrence rates, making the treatments ever more appealing to patients and healthcare professionals alike.

Increasing Focus on Cosmetic and Aesthetic Treatments
Although varicose veins are primarily a medical condition, a growing number of patients seek treatment for cosmetic reasons. Visible varicose veins, particularly on the legs, lead to self-consciousness and aesthetic dissatisfaction, and patients increasingly choose minimally invasive treatments like laser therapy and sclerotherapy. 

The rising social media impact, beauty consciousness, and disposable income in developed economies like North America and Europe have increased the demand for quick and effective aesthetic vein treatments. Dermatology and beauty clinics are expanding their services to offer varicose vein removal services, leading to a wider consumer base. Additionally, the increased application of sophisticated laser and radiofrequency devices in cosmetic dermatology clinics further increases the market growth.

Global Varicose Vein Treatment Market: Research Scope and Analysis

By Treatment Type Segment Analysis

Endovenous ablation is projected to be the leading treatment type in the global varicose vein treatment market as it holds 36.0% of the market share in 2025 because it is minimally invasive, has high success rates, and provides a quicker recovery time than traditional surgery. The treatment, which includes endovenous laser therapy (EVLT) and radiofrequency ablation (RFA), is widely accepted by both patients and doctors for its long-term results with minimal pain. Compared to surgical vein stripping which requires incisions, general anesthesia, and longer recovery durations, endovenous ablation is performed through catheter-based treatments that seal the diseased vein by delivering controlled heat energy.

One main reason for the dominance of endovenous ablation is that it has a high success rate of over 95% with low recurrence when compared to other therapies like sclerotherapy and compression therapy. Another factor is the development in technology in laser and radiofrequency equipment, which has made the procedures safer and more efficient, reducing post-operative complications such as infection and nerve damage. The procedure is often performed on an outpatient basis, and thus it is cost-saving and convenient for both patients and healthcare institutions.

Moreover, the growing prevalence of varicose veins, particularly in aging populations, obese individuals, and those who have occupations that require long hours of standing, has created the necessity for efficient, minimally invasive procedures. Insurance coverage for endovenous ablation has also increased for developed economies like the U.S. and Europe, making the procedure more accessible to patients. The combination of improved clinical outcomes, patient preference, and continued innovation in technology has consolidated the role of endovenous ablation as the dominant treatment modality in the varicose vein treatment market.

By End-User Segment Analysis

Hospitals are anticipated to be at the forefront of the end-user segment of the varicose vein treatment market due to their large-scale healthcare infrastructure, availability of the latest medical technologies, and ability to treat complex cases. Unlike ambulatory surgery centers and specialty clinics, hospitals offer a multidisciplinary varicose vein treatment, ensuring that patients with advanced venous diseases, comorbidities, or high-risk factors are managed by vascular surgeons, interventional radiologists, and other specialists.

Among the major reasons for the dominance of hospitals in this market is that they offer a wide range of varicose vein treatments, including endovenous ablation, sclerotherapy, and surgical vein stripping. Hospitals also invest in newer diagnostic devices such as Doppler ultrasound and AI-based vein mapping that are required for proper treatment planning. Advanced laser and radiofrequency devices in hospitals translate to the fact that hospitals can deliver effective and quality care, further solidifying their market position.

Additionally, hospitals have higher patient volumes due to referrals from other specialists and general practitioners. They also admit both insured and uninsured patients, making varicose vein treatments more accessible. Another significant advantage that hospitals have is the ability to manage post-treatment complications, such as deep vein thrombosis (DVT) and nerve damage, that require specialized medical care and emergency response.

Also, in nations where universal healthcare systems prevail, varicose vein treatments are typically covered under hospital-based insurance schemes, which increases the volume of patients treated in hospitals as opposed to standalone clinics. As hospitals continue to expand their vascular care departments and implement AI-based diagnostic solutions, their dominance in the market for varicose vein treatments is expected to persist.

The Global Varicose Vein Treatment Market Report is segmented on the basis of the following

By Treatment Type

• Endovenous Ablation
• Endovenous Laser Treatment (EVLT)
• Endovenous Radiofrequency Ablation (RFA)
• Sclerotherapy
• Ultrasound-Guided Foam Sclerotherapy
• Liquid Sclerotherapy
• Surgical Procedures
• Vein Stripping
• Ambulatory Phlebectomy
• Compression Therapy

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Global Varicose Vein Treatment Market: Regional Analysis

Region with Highest Market Share in the Varicose Vein Treatment Market

North America is projected to be the biggest varicose vein treatment market globally with 37.10% of the total revenue by the end of 2025, attributed to the large prevalence of disease, highly developed healthcare infrastructure, and good adoption of minimally invasive procedures. The region is experiencing a high rate of varicose veins, particularly among the aging population, obese individuals, and working individuals with long-standing jobs. The U.S. has the biggest market share, driven by the favorable reimbursement environment, large healthcare expenditure, and highly developed vascular care facility network.

The leadership is also supported by technological innovation, with leading manufacturers in North America constantly developing next-generation treatment solutions. The increasing demand for endovenous ablation procedures, supported by FDA approvals of new devices, has spawned a boom for outpatient procedures. Additionally, the presence of world-class vascular specialists and promotional campaigns for early diagnosis and treatment further boost market growth. The high rate of insurance penetration in the U.S. ensures that patients are capable of accessing quality treatment solutions, further consolidating North America’s leadership.

Region with the Highest CAGR in the Varicose Vein Treatment Market

The Asia-Pacific is experiencing the highest CAGR in the varicose vein treatment market, primarily due to increasing healthcare expenditure, rising awareness, and a rapidly aging population. The region is confronting increasing demand for minimally invasive procedures, driven by urbanization, sedentary lifestyles, and rising obesity. China, India, and Japan are leading this expansion, fueled by rising medical tourism, decreasing treatment costs, and government initiatives to improve vascular healthcare services.

Increasing demand for laser and radiofrequency ablation devices, as well as the increasing number of specialty clinics and ambulatory surgery centers, has accelerated market growth at a higher rate. The presence of local and multinational players investing in product development and distribution networks is also leading to the rapid adoption of novel varicose vein treatment devices. Expanding private healthcare facilities and increasing availability of insurance coverage in emerging economies additionally boost market growth, with Asia-Pacific being the fastest-growing market.

By Region

North America

• The U.S.
• Canada

Europe

• Germany
• The U.K.
• France
• Italy
• Russia
• Spain
• Benelux
• Nordic
• Rest of Europe

Asia-Pacific

• China
• Japan
• South Korea
• India
• ANZ
• ASEAN
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America

Middle East & Africa

• Saudi Arabia
• UAE
• South Africa
• Israel
• Egypt
• Rest of MEA

Global Varicose Vein Treatment Market: Competitive Landscape

The global varicose vein treatment market is highly competitive, and key players are focusing on technological development, mergers, acquisitions, and strategic partnerships to grow their market share. Key players such as Medtronic, Boston Scientific, and AngioDynamics have a significant market share due to their strong product portfolios and extensive distribution networks. These players continuously invest in R&D to develop next-generation endovenous ablation systems and laser treatment products.

In addition, the regional players in the Asia-Pacific and Europe are expanding their market share through strategic collaborations and acquisitions. The market is witnessing a rise in FDA and CE approvals, which is allowing the manufacturers to introduce highly effective and patient-friendly devices. The companies also invest in AI-based diagnostics and robotic-assisted vein treatment solutions for enhancing procedural accuracy.

The industry also sees increased activity in global healthcare expos and conferences, where companies showcase new treatment solutions. With the demand for minimally invasive treatments increasing, the competition is expected to get fierce, promoting constant innovation and new product launches in the market.
Some of the prominent players in the Global Varicose Vein Treatment Market are

• Medtronic plc
• Boston Scientific Corporation
• AngioDynamics, Inc.
• Teleflex Incorporated
• Merit Medical Systems, Inc.
• BTG International Ltd (a Boston Scientific company)
• VVT Medical Ltd.
• F care Systems
• Energist Ltd.
• Sciton, Inc.
• Dornier MedTech GmbH
• Candela Medical
• Alma Lasers (Sisram Medical)
• Lumenis Ltd.
• Asclepion Laser Technologies GmbH
• Biolitec AG
• Syneron Medical Ltd.
• Medelux
• Inari Medical, Inc.
• Theraclion
• Other Key Players

Recent Developments in the Global Varicose Vein Treatment Market

2025

• March 2025: Medtronic invested $80 million in AI-powered vein treatment technology to improve precision and efficiency in endovenous ablation procedures, advancing minimally invasive solutions for varicose vein treatment.
• January 2025: Boston Scientific introduced a new radiofrequency (RF) ablation system for varicose vein treatment at the International Vascular Conference, highlighting enhanced safety, faster recovery, and improved procedural efficacy.

2024

• November 2024: AngioDynamics acquired a European vascular device manufacturer for $150 million, strengthening its global footprint in minimally invasive varicose vein treatments and expanding its advanced product portfolio.
• September 2024: Lumenis Ltd. partnered with top Indian hospitals to introduce affordable laser vein treatment programs, increasing accessibility to advanced therapies in emerging healthcare markets.
• July 2024: Teleflex launched a next-gen RF vein closure device, designed to reduce procedure time, minimize patient discomfort, and enhance clinical outcomes in varicose vein treatment.
• May 2024: BTG International (Boston Scientific) showcased breakthroughs in sclerotherapy and endovenous laser treatment at the Global Phlebology Expo, promoting cutting-edge, minimally invasive solutions.

2023

• December 2023: Alma Lasers expanded its R&D center in Germany, focusing on developing next-generation laser technology for more precise and effective varicose vein treatments.
• August 2023: Inari Medical partnered with vascular clinics across North America to provide specialized training programs for advanced varicose vein treatment procedures.
• April 2023: Biolitec AG secured regulatory approvals in Japan and South Korea for its latest laser vein treatment system, strengthening its Asia-Pacific market expansion.